SCHEMBL25415474

SCHEMBL25415474

CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CN1C(=O)C=CC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 1/20 0.47
▸ GSK3B P49841 1/20 0.47
▸ LMNA P02545 2/20 0.45
▸ MGLL Q99685 1/20 0.42
▸ PKM P14618 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ TSHR P16473 2/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ DDAH1 O94760 1/20 0.38
▸ ASAH1 Q13510 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18470775 0.91 GSK3A (0.44) GSK3AGSK3BLMNAMGLLPKM
SCHEMBL20677173 0.91 GSK3A (0.44) GSK3AGSK3BLMNAMGLLPKM
SCHEMBL29398370 0.91 GSK3A (0.44) GSK3AGSK3BLMNAMGLLPKM
SCHEMBL13541914 0.91 LMNA (0.47) GSK3AGSK3BLMNAMGLLPKM
SCHEMBL24797572 0.87 MGLL (0.43) GSK3AGSK3BLMNAMGLLPKM
SCHEMBL22311942 0.87 MGLL (0.43) GSK3AGSK3BLMNAMGLLPKM
SCHEMBL27388123 0.87 MGLL (0.43) GSK3AGSK3BLMNAMGLLPKM
SCHEMBL24797571 0.87 MGLL (0.43) GSK3AGSK3BLMNAMGLLPKM
SCHEMBL24255821 0.87 MGLL (0.43) GSK3AGSK3BLMNAMGLLPKM
SCHEMBL20338051 0.87 LMNA (0.45) GSK3AGSK3BLMNAMGLLPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024129956-A1 THIENOAZEPINE IMMUNOCONJUGATES, AND USES THEREOF BOLT BIOTHERAPEUTICS, INC. (US) 2024-06-20 — — WO disclosed
EP-4313161-A1 2-AMINO-4-CARBOXAMIDE-BENZAZEPINE IMMUNOCONJUGATES, AND USES THEREOF Bolt Biotherapeutics, Inc. (US) 2024-02-07 — — EP disclosed
WO-2023154302-A1 MACROMOLECULE-SUPPORTED 8-SULFONYL-BENZAZEPINE COMPOUNDS AND THEIR USES BOLT BIOTHERAPEUTICS, INC. (US) 2023-08-17 — — WO disclosed
Send feedback